GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (STU:YP1B) » Definitions » E10

Immutep (STU:YP1B) E10 : €0.00 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Immutep E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Immutep's adjusted earnings per share data for the three months ended in Dec. 2024 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-17), Immutep's current stock price is €0.161. Immutep's E10 for the quarter that ended in Dec. 2024 was €0.00. Immutep's Shiller PE Ratio of today is .


Immutep E10 Historical Data

The historical data trend for Immutep's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immutep E10 Chart

Immutep Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Immutep Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Immutep's E10

For the Biotechnology subindustry, Immutep's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immutep's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immutep's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immutep's Shiller PE Ratio falls into.



Immutep E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immutep's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/129.4637*129.4637
=0.000

Current CPI (Dec. 2024) = 129.4637.

Immutep Quarterly Data

per share eps CPI Adj_EPS
201006 -0.022 88.971 -0.032
201106 -0.024 92.129 -0.034
201112 -0.059 92.686 -0.082
201206 -0.089 93.244 -0.124
201212 -0.050 94.730 -0.068
201306 -0.055 95.473 -0.075
201312 -0.031 97.330 -0.041
201406 -0.030 98.352 -0.039
201412 -0.033 99.002 -0.043
201506 -0.123 99.838 -0.159
201512 -0.186 100.673 -0.239
201603 -0.008 100.488 -0.010
201606 0.010 100.859 0.013
201612 -0.013 102.159 -0.016
201703 -0.008 102.624 -0.010
201706 -0.007 102.809 -0.009
201712 -0.011 104.110 -0.014
201806 -0.019 104.945 -0.023
201812 -0.017 105.967 -0.021
201906 -0.015 106.617 -0.018
201912 -0.009 107.917 -0.011
202006 -0.011 106.246 -0.013
202009 0.000 107.917 0.000
202012 -0.023 108.846 -0.027
202103 0.000 109.496 0.000
202106 -0.008 110.332 -0.009
202109 0.000 111.168 0.000
202112 -0.012 112.654 -0.014
202203 0.000 115.069 0.000
202206 -0.012 117.112 -0.013
202209 0.000 119.248 0.000
202212 -0.015 121.477 -0.016
202303 0.000 123.148 0.000
202306 -0.013 124.170 -0.014
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000
202403 0.000 127.606 0.000
202406 0.000 128.906 0.000
202409 0.000 129.185 0.000
202412 0.000 129.464 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Immutep  (STU:YP1B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Immutep E10 Related Terms

Thank you for viewing the detailed overview of Immutep's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Immutep Business Description

Traded in Other Exchanges
Address
264 George Street, Level 32, Australia Square, Sydney, NSW, AUS, 2000
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Immutep Headlines

No Headlines